glp-1 regulatory news Pharmacovigilance Assessment of Compounded Receptor Agonists: Insights From the FDA Adverse Event Reporting System Mechanisms of GLP-1 Receptor Agonist-Induced
Description
It eliminates the need for ongoing medication management and the associated risks of adverse drug interactions

This effect is also observed after specific activation of GLP-1R in the NAc and most likely those receptors located on medium spiny neurons that express the dopamine-D1 receptors or dopamine-D2 receptors (Zhang et al., 2020)

Weight loss outcomes were larger than those seen in the STEP trials

In parallel, glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide and tirzepatide, have transformed the therapeutic landscape of T2D and obesity by producing profound weight reduction, improvements in glycemic control, and cardiovascular risk reduction [7,8]

Gastroenterologists generally prefer Miralax for GLP-1 users

The exact number of days varies by brand and even by formulation, so this is one of those times where reading the little paper insert that comes in the box genuinely matters
